Already, scientists have shown that GLP-1 drugs like semaglutide can lower the risk of heart attack and stroke, reduce signs of kidney and liver disease and treat sleep apnea, among other effects
Clinical trials have shown that study participants who took Semaglutide GLP-1 once a week lost an average of 5-10% of their body weight
The presentations are titled A 12-week Trial of MET-097A Potent and Ultra-Long-Acting GLP-1 Receptor Agonist Safety, Tolerability, PK, and Efficacy of MET-097A Next-Generation Nutrient-Stimulated Hormone Peptide Analog for Chronic Weight Management
GLP-1s are on track to be one of the most profitable drug classes of all time and everyone wants in on the action
The most common side effectsnausea, diarrhea, constipation, and abdominal painare generally mild to moderate and improve with continued treatment